Company Announces Update to Phase 3 XPORT-EC-042 Trial of Selinexor as Maintenance Therapy in Advanced or Recurrent TP53 Wild-Type Endometrial ...

Immunotherapy is leading the charge in the advancement of cancer treatment. In addition to increased life expectancy, it ...

The chemical creates trihalomethanes (THMs) that increase the risk of bladder cancer by 33 percent and colorectal cancer by ...

My annual scan showed no cancer recurrence, but revealed some minor issues related to aging and potential fibroids, requiring ...

Promising Liver Cancer Therapies such as Atezolizumab, Bevacizumab, Tiragolumab, OH2 injection, MTL-CEBPA, Sorafenib 200mg, ...